SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Yatsen Holding Ltd
Date: July 3, 2025 · CIK: 0001819580 · Accession: 0000000000-25-007077

Financial Reporting Internal Controls Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-39703

Date
July 3, 2025
Author
Division of
Form
UPLOAD
Company
Yatsen Holding Ltd

Letter

Re: Yatsen Holding Limited Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-39703 Dear Donghao Yang:

July 3, 2025

Donghao Yang Chief Financial Officer Yatsen Holding Limited Floor 39, Poly Development Plaza No. 832 Yue Jiang Zhong Road, Haizhu District Guangzhou, 510335 People s Republic of China

We have reviewed your filing and have the following comments.

Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response.

After reviewing your response to this letter, we may have additional comments.

Form 20-F filed April 22, 2025 Note 1, page F-14

1. Your disclosure here reports a 100% beneficial ownership interest in the VIE whereas your disclosure on page 5 indicates that the VIE is 100% owned by two individuals. Please expand your disclosure on page F-14 to distinguish between your controlling interest and your actual ownership interest. Note 8, page F-32

2. We note that your equity method investments comprise over 16% of your total assets. Please explain to us why your equity in Income from equity method investments balance on page F-7 has decreased substantially even though your disclosure on page F-33 reports increases in the revenues and income of these investees. Please also clarify for us whether you have received any dividends from these investees. For each of the equity investees referenced in footnotes (a) and (b), please describe in detail the objective evidence you considered in concluding that no impairment charges were July 3, 2025 Page 2

required in 2024. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tayyaba Shafique at 202-551-2110 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters.

Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 July 3, 2025

Donghao Yang
Chief Financial Officer
Yatsen Holding Limited
Floor 39, Poly Development Plaza
No. 832 Yue Jiang Zhong Road, Haizhu District
Guangzhou, 510335
People s Republic of China

 Re: Yatsen Holding Limited
 Form 20-F for Fiscal Year Ended December 31, 2024
 File No. 001-39703
Dear Donghao Yang:

 We have reviewed your filing and have the following comments.

 Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

 After reviewing your response to this letter, we may have additional
comments.

Form 20-F filed April 22, 2025
Note 1, page F-14

1. Your disclosure here reports a 100% beneficial ownership interest in the
VIE whereas
 your disclosure on page 5 indicates that the VIE is 100% owned by two
individuals.
 Please expand your disclosure on page F-14 to distinguish between your
controlling
 interest and your actual ownership interest.
Note 8, page F-32

2. We note that your equity method investments comprise over 16% of your
total assets.
 Please explain to us why your equity in Income from equity method
investments
 balance on page F-7 has decreased substantially even though your
disclosure on page
 F-33 reports increases in the revenues and income of these investees.
Please also
 clarify for us whether you have received any dividends from these
investees. For each
 of the equity investees referenced in footnotes (a) and (b), please
describe in detail the
 objective evidence you considered in concluding that no impairment
charges were
 July 3, 2025
Page 2

 required in 2024.
 We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

 Please contact Tayyaba Shafique at 202-551-2110 or Al Pavot at
202-551-3738 if you
have questions regarding comments on the financial statements and related
matters.

 Sincerely,

 Division of
Corporation Finance
 Office of Industrial
Applications and
 Services
</TEXT>
</DOCUMENT>